World's first malaria vaccine and its significance to malaria control in Africa

• 作者: Eunice A Owino
• 来源期刊: 亚太热带医药杂志（英文版）
• 年，卷（期）: 2022,（2）
• 所属期刊栏目: Perspectives
• 页码范围: 49-52
• 页数: 4页
• 语种: 英文
• DOI: 10.4103/1995-7645.338435

摘要

In October 2021,the World Health Organization(WHO)endorsed the first malaria vaccine,as a complementary tool for widespread use among children in at-risk areas;sub-Saharan Africa and in other regions with moderate to high Plasmodium falciparum malaria transmission,including our country,Kenya[1].The breakthrough followed three decades of clinical trials in seven African countries including Ghana,Kenya and Malawi,where a large-scale pilot programme coordinated by the WHO since 2019,administered 2.3 million doses of Mosquirix,the malaria vaccine,to infants[1].